World Health Organization say Irish scientist's COVID vaccine is the "leading candidate"

Chinese coronavirus vaccine approved for military use

The experimental shot is the first ever candidate from India to be approved for the clinical trial stage, which is set to begin across the country from July.

The company is also involved in the development of CoroFlu, a nasal vaccine for COVID-19, as part of an global collaboration of virologists at the University of Wisconsin-Madison and vaccine firm FluGen. "We're now ready to move forward into clinical development through human trials", Krishna Ella, Bharat's chairman and managing director, said.

Human clinical trials are scheduled to start across India in July, according to a release from the company late on Monday evening.

Besides Bharat Biotech, at least five other Indian companies are working on a vaccine for the deadly coronavirus including Zydus Cadila, Serum Institute of India and Panacea Biotec. The indigenous, inactivated vaccine developed and manufactured at the Bio-safety level 3 lab of the Bharat Biotech located in Genome Valley in Hyderabad.

China's military has approved a coronavirus vaccine for use within its ranks. The proactive support and guidance from CDSCO have enabled approvals to this project.


Chinese companies and researchers have been allowed to test eight vaccine candidates in humans at home and overseas, making China a major front-runner in the race to develop a shot against the virus that has killed almost 500,000 people globally. CNBG said on Tuesday it will run a Phase 3 for its vaccine candidate in the United Arab Emirates, without specifying which shot will be tested. "Our R&D and manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform". Over a dozen vaccine candidates are now in development around the world, including several from China.

Earlier this month, the AstraZeneca CEO told a radio station that the vaccine candidate would likely provide protection against Covid-19 for one year.

American firm Moderna Inc., which has already started Phase II trials for its vaccine candidate mRNA-1273, has partnered with drugmaker Catalent Inc.to produce 100 million doses starting in the third quarter of 2020.

Doctors are also testing various drugs to find out their effectiveness in fighting against the COVID-19 virus.

China reported 12 new confirmed Covid-19 cases as ofSunday, down from 17 reported a day earlier, the country's National Health Commission said yesterday.

Related:

Comments

Latest news

Kylie Jenners birthday surprise for Khloé Kardashian will leaves fans in shock
Rob also posed with his big sis Kourtney Kardashian on the way into the bash. "Appreciate it", he wrote together with the snap. But the photos he shared on Instagram on Sunday, June 28, are what had fans' jaws on the floor.

Marcus Rashford will score soon says Manchester United manager Ole Gunnar Solskjaer
Whilst there are no fresh injury concerns for the Old Trafford side, Axel Tuanzebe and Phil Jones remain out. The match will be broadcast live on Sky Sports Main Event, Sky Sports Premier League, Sky One and Sky Pick.

Football Moment that Left us Speech-Less.
With an 11- 0 score at the end of the game, Germany started the Shanghai Women’s World Cup with a world record win. Women’s World Cup 2007 Germanys women’s team opened the World Cup with a bang against Argentina.

How Arsenal Transfer News Affect Their Odds to Win?
Other players rumored to be destined for Arsenal include; Sokratis Papastathopoulos, from Borussia Dortmund, and Saul Niguez. If they are rumored to buy an elite player, during the transfer window, they play well which increases the odds of winning.

London’s Medical Startups Challenge Welcomes a New Judge, Max Polyakov
MBios is a joint project of Innovation House and the Ukrainian Medical Association of the United Kingdom (UMAUK). Such kind of challenges provides the participants with an opportunity to present their projects to the world.

Other news